Search company, investor...

Century Pharmaceuticals

centurypharma.com

Founded Year

1982

Stage

Other Investors | Alive

About Century Pharmaceuticals

Century Pharmaceuticals is a generic drug manufacturer based in India.

Headquarters Location

406, World Trade Centre Sayajigunj

390005,

India

Missing: Century Pharmaceuticals's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Century Pharmaceuticals's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Century Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Century Pharmaceuticals is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

Latest Century Pharmaceuticals News

Global Sildenafil Market 2021:Size,Share,Growth Rate,Opportunities,Covid-19 Impact Analysis,Forecast To 2028||Players-Pfizer Inc., Century Pharmaceuticals Ltd., Polpharma, Deva Holdings, Actavis, Inc., Accord-UK Ltd., Mantra Pharma, ANGITA, Apotex Inc., Bayer AG

May 10, 2021

||Players-Pfizer Inc., Century Pharmaceuticals Ltd., Polpharma, Deva Holdings, Actavis, Inc., Accord-UK Ltd., Mantra Pharma, ANGITA, Apotex Inc., Bayer AG Data Bridge Market Research has provides the Qualitative and informative knowledge by adding titled “ Global Sildenafil Market , By Product Type (Branded and Generics), Application (Peripheral Vasodilator and Erectile Dysfunction), End-Users (Clinics, Hospitals, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.”In this report, Researchers have analyzed Strength, Weakness, opportunities and threats in the market and provides the unbiased picture of the market with the Qualitative and informative knowledge. The Sildenafil Market report additionally states import/trade utilization, free market activity figures, cost, value, volume and gross edges. Sildenafil market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 4.80% and is expected to reach USD 2,096.19 million by 2028 in the above-mentioned research forecast period. Download Free Exclusive Sample (350 Pages PDF) Report: To Know the Impact of COVID-19 on this Industry@ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-sildenafil-market Sildenafil is phosphodiesterase inhibitor and is indicated for the treatment of erectile dysfunction in men. This medicine improves the exercise ability in adults suffering from pulmonary arterial  hypertension . It treats erectile dysfunction by enhancing the blood flow to the penis during sexual stimulation. This increase in  blood  flow leads to an erection. Sildenafil works by relaxing the blood vessels of lungs, which allows easy blood flow. The major players covered in the sildenafil market are Pfizer Inc., Century Pharmaceuticals Ltd., Polpharma, Deva Holdings, Actavis, Inc., Accord-UK Ltd., Mantra Pharma, ANGITA, Apotex Inc., Bayer AG, Ritz Formulations Pvt. Ltd., Cipla, Abbott, Viatris Inc., Sandoz, Hetero Healthcare Limited, Delphis Pharma, Teva Pharmaceuticals USA, Inc., Lupin Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC., Umang Pharmaceuticals among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately. Regional analysis for Sildenafil Market includes: North America Patient Epidemiology Analysis Sildenafil market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period. Core Objectives of Sildenafil market research To analyze global Sildenafil status, future forecast, growth opportunity, key market and key players. To present the Sildenafil development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. Global Sildenafil Market Scope and Market Size Sildenafil market is segmented on the basis of product type, application, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets. On the basis of product type, the sildenafil market is segmented into branded and generics. On the basis of application, the sildenafil market is segmented into peripheral vasodilator and erectile dysfunction. On the basis of end-users, the sildenafil market is segmented into clinics, hospitals, and others. On the basis of distribution channel, the sildenafil market is segmented into hospital pharmacy, retail pharmacy, online pharmacy and others. Make An Enquiry and Ask For Customized Report@ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-sildenafil-market Competitive Landscape and Sildenafil Market Share Analysis Sildenafil market competitive landscape provides details by competitor details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Sildenafil market. Global Sildenafil Market Drivers: Presence of branded drugs and increasing prevalence of erectile dysfunction worldwide. Moreover, rising awareness and increasing prevalence of  diabetes  and obesity also boost up the market growth. Growing  geriatric  population and rising healthcare expenditure act as an opportunity for market growth. However, side effects caused by drugs and a strict regulatory framework may hamper the global sildenafil market. As per the studies conducted, this has been reported that erectile dysfunction is highly prevalent with 3-76.5% prevalence rate and it increases with an increase in age. This affected population is hugely dependent upon sildenafil to achieve better treatment, hence providing lucrative growth. Table of Content: Emerging segments and regional markets Testimonials to companies in order to fortify their foothold in the Sildenafil market. Reasons To Purchase Sildenafil Market Report Covered: The Sildenafil market report analyses how market will progress in the coming years. Analyzing several views of the Sildenafil market with the benefit of Porter’s five forces analysis. Identify the new progresses, Sildenafil market shares and policies employed by the major market players. Study on the product type that is projected to dominate the market and regions that are expected to witness the fastest growth during the forecast period Competitive landscape including the Sildenafil market share of major players along with the key strategies known for growth in the past five years Complete company profiles covering the product offerings, key financial information, recent developments, SWOT analysis and strategies employed by the major Xyz market players About Us: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing  sopan.gedam@databridgemarketresearch.com  . We are content with our glorious 99.9 % client satisfying rate. Contact:

Century Pharmaceuticals Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Century Pharmaceuticals Rank

Century Pharmaceuticals Frequently Asked Questions (FAQ)

  • When was Century Pharmaceuticals founded?

    Century Pharmaceuticals was founded in 1982.

  • What is Century Pharmaceuticals's latest funding round?

    Century Pharmaceuticals's latest funding round is Other Investors.

  • Who are the investors of Century Pharmaceuticals?

    Investors of Century Pharmaceuticals include GVFL and Gujarat Biotechnology Venture Fund.

  • Who are Century Pharmaceuticals's competitors?

    Competitors of Century Pharmaceuticals include Novast Pharmaceuticals, Kala Pharmaceuticals, Sequel Pharmaceuticals, Peckforton Pharmaceuticals, ANI Pharmaceuticals and 9 more.

Compare Century Pharmaceuticals to Competitors

N
Novast Pharmaceuticals

Novast is a generic and specialty pharmaceutical company, operated in both China and the United States. Novast is dedicated to upholding the highest quality and drug delivery technology in product development and commercial manufacturing. The company integrates science and technology with quality in all disciplines to develop and supply cost-effective and affordable products with global strategic alliances for the worldwide regulated markets.

P
Pondera Pharmaceuticals

Pondera Pharmaceutical is a stealth mode pharmaceuticals company.

F
Fada Pharma

Fada Pharma is Argentina's leading manufacturer of generic pharmaceuticals for the institutional market

H
Heritage Pharmaceuticals

Heritage Pharmaceuticals Inc. is a rapidly growingngeneric pharmaceutical company engaged in thenacquisition, licensing, development, marketing,nsale and distribution of generic pharmaceuticalnproducts for the global prescriptionndrug markets.n nHeritage has established itself as a competitor in thengeneric pharmaceutical industry by initially targetingnniche products with revenues that are generally toonsmall to command the resources and attention ofnmajor market participants. Heritage launched its U.S. label in 2006 and has rapidly built a portfolio of highnquality multi-source generic pharmaceutical productsnacross multiple therapeutic categories, including: ncardiovascular, pain management, anti-infectives andnmetabolic disease.n nThe company's business model aims to utilize strategicnoutsourcing to U.S.F.D.A. qualified manufacturingnand development organizations in both NorthnAmerica and Asia. The Company will continuento introduce its new generic products during 2008nfollowing its tradition quality, value andnservice in generics.

B
Bridge Pharmaceutical

Bridge Pharmaceutical aims to "bridge the gap" between the U.S. and Asia drug industries by transferring top FDA-compliant development technology to Asia.

G
GeneraMedix

GeneraMedix Inc. is a pharmaceutical company that develops, markets and distributes generic injectable products. nnThe company's MissionnnThe company aims to bring to market generic products where the active pharmaceutical ingredient is difficult to source, manufacturing or regulatory hurdles exist and are difficult to overcome, or where product is in short supply. n

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.